What Sotera Health Company's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 3 | 18 |
| Total trades | 4 | 51 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 687,472 |
| Disposed | 850,000 | 1,520,901 |
| Net activity | −850,000 | −833,429 |
Common stock only — 32 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Petras Michael B. Jr. | Executive Chairman | Aug 17 | Open-market sale · S | −850,000 | $18.50 | −$15.7M | 3,969,393 |
| Petras Michael B. Jr. | Executive Chairman | Aug 17 | Open-market sale · S | −294,515 | $18.50 | −$5.45M | 397,912 |
| Rutz Michael P | President of Sterigenics | Aug 07 | Open-market sale · S | −150,000 | $18.84 | −$2.83M | 334,279 |
| Lyons Jonathan M. | Sr. Vice President, CFO | Aug 05 | Withheld — tax / exercise cost · F | −11,316 | $17.98 | −$203K | 217,304 |
| Shader Alton | Chief Executive Officer | May 26 | Grant / award · A | +203,634 | — | — | 579,573 |
| Shader Alton | Chief Executive Officer | May 26 | Grant / award · A | +375,939 | — | — | 375,939 |
| Wheadon David E. | Director | May 22 | Grant / award · A | +14,970 | — | — | 89,882 |
| Chen Ruoxi | Director | May 22 | Grant / award · A | +14,970 | — | — | 95,751 |
| Cunningham Sean Laurence | Director | May 22 | Grant / award · A | +14,970 | — | — | 95,751 |
| Simon, Christopher | Director | May 22 | Grant / award · A | +14,970 | — | — | 34,102 |
| Petrella Vincent K | Director | May 22 | Grant / award · A | +14,970 | — | — | 95,751 |
| Neary James | Director | May 22 | Grant / award · A | +14,970 | — | — | 95,751 |
| Flynn Karen | Director | May 22 | Grant / award · A | +14,970 | — | — | 54,191 |
| Klee Ann R. | Director | May 22 | Grant / award · A | +14,970 | — | — | 140,926 |
| Krause Kenneth D. | Director | May 22 | Grant / award · A | +14,970 | — | — | 14,970 |
| Kyle Richard G | Director | May 22 | Grant / award · A | +14,970 | — | — | 14,970 |
| Warburg Pincus & Co. | Director | May 13 | Open-market sale · S | −19,102,952 | $15.17 | −$290M | 0 |
| Gtcr Investment Xi Llc | Director | May 13 | Open-market sale · S | −12,735,301 | $15.17 | −$193M | 0 |
| Warburg Pincus & Co. | Director | May 13 | Open-market sale · S | −19,102,952 | $15.17 | −$290M | 0 |
| Dimitrief Alexander | Former SVP, GC and Sec. | Mar 31 | Withheld — tax / exercise cost · F | −7,941 | $14.34 | −$114K | 312,040 |
Loading...
